盘后交易 17:36 (美东)49.900USD-0.100-0.20%关键数据
48.550今开
51.852最高
116.95K成交量
亏损市盈率 TTM
65.61市盈率动
--股息TTM
0.20%换手率
48.750昨收
47.570最低
5.80M成交额
亏损市盈率静
6.02市净率
0.00%股息率 TTM
-12.95%ROA
52.91052周最高
0.07量比
-9.96M净利润
59.73M总股本
-0.6358每股收益TTM
0.94Beta
-17.96%ROE
23.00052周最低
8.78%振幅
74.81%毛利率
2.99B总市值
7.85回报/风险
3.74%风险率

即将为您带来更多新闻,敬请期待。。。
AxoGen Inc评分
0.02与上次评分对比预测8.40
财务诊断8.61
技术分析5.91
公司估值8.30
机构认同度10.00
风险评估5.24
分析师评级
买入评级
59.091目标均价
+19.69%涨幅空间
AxoGen Inc 最新财报电话会记录
Axogen (AXGN) 2026年第三季度业绩电话会:营收增长26%,上调业绩指引
受乳房业务增长超60%推动,Axogen 2026年第三季度营收增长26.2%至7580万美元。该公司已将2026年营收指引上调至至少2.9亿美元。
财务指标
货币: USD

由于公司未披露,未能获取相关数据
货币: USD

由于公司未披露,未能获取相关数据
AxoGen Inc 简介
Axogen, Inc. is focused on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. It offers repair solutions for surgeons and healthcare providers. Its portfolio of products includes Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard HA+ Nerve Protector, Axoguard Nerve Cap, and Avive+ Soft Tissue Matrix. Avance Nerve Graft is a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves. The Axoguard Nerve Connector is a porcine (pig) submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves. Axoguard Nerve Protector is a porcine submucosa ECM product used to wrap and protect damaged peripheral nerves and reinforce the nerve reconstruction while preventing soft tissue attachments. Axoguard HA+ Nerve Protector consists of a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel coating.
行业医疗设备与耗材
公司代码AXGN
员工数量451
国家United States of America
持股情况
| 持股股东 | 占比 |
|---|
| First Light Asset Management, LLC | 6.19% |
|---|
| BlackRock Institutional Trust Company, N.A. | 6.16% |
|---|
| Morgan Stanley & Co. LLC | 4.56% |
|---|
| Vanguard Capital Management, LLC | 4.31% |
|---|
| 股东类型 | 占比 |
|---|
| Investment Advisor/Hedge Fund | 34.99% |
|---|
| Investment Advisor | 32.71% |
|---|
| Hedge Fund | 11.37% |
|---|
| Research Firm | 6.91% |
|---|
常见问题
AxoGen Inc(AXGN)的当前股价是多少?
AxoGen Inc(AXGN)的当前股价是 50.02。
AxoGen Inc股票的52周最高点是52.91。
AxoGen Inc股票的52周最低点是23.00。
现在AxoGen Inc(AXGN)的股票是买入、持有还是卖出?
根据分析师评级,AxoGen Inc(AXGN)的总体评级为买入,目标价格为59.09。
AxoGen Inc(AXGN)股票的每股收益(EPS TTM)是多少
AxoGen Inc(AXGN)股票的每股收益(EPS TTM)是-0.64。